Connect with us

Business

Turning back the clock to 20/20 vision with refractive surgeries (Lasik and Lasek)

Published

on

It is no surprise that most people reduced to wearing eyeglasses or contact lenses due to visual restrictions, would love to turn back the clock to days of 20/20 vision. Without the daily hindrances of glasses or lenses, life is just that bit more freeing, enjoyable and unhampered by a constant demand.

For over 25 years now, refractive surgeries such as Lasik (Laser In-Situ Keratomileusis) and Lasek (Laser Assisted Sub-Epithelial Keratectomy), has been a place of refuge and miracle for many looking to restore their vision to its former glory. But there are still others that have not heard about these procedures, while many more lack full awareness of the process, famed for its quick results and painless nature. It should however be mentioned, that while many undergoing Lasik or Lasek achieve 20/20 vision, some still eventually might require glasses for driving at night or even reading as they age.

However, not all who want to refractive surgery qualify to receive it. Patients should be between the ages of 18 to 45 with generally healthy eyes and cornea free of disease. They are first screened thoroughly and asserted that they have suffered from stable refractive errors for atleast one year, with nearsightedness, farsightedness or astigmatism, while their cornea is also measured for thickness and structural normality. Those who are pregnant or nursing also do not qualify to refractive surgery within this period.

Refractive Surgery consists of three parts, and is performed on an “outpatient basis” on the day of the surgery. First, anesthetic eye drops are administered to numb the eye to accommodate a comfortable, painless surgery experience for the patient. The eyelids will be then be kept open by a device called a ‘speculum’, while the patient is requested to fixate his vision on a red light during the procedure.

In Lasik Surgery, a thin flap of corneal tissue is peeled off with one end of it still attached to the cornea, after which the cornea is reshaped to suit individual requirements by Excimer laser. Thereafter, excimer lasers create a cool light beam to remove microscopic amounts of tissue from the cornea to reshape it so light entering the eye focuses more accurately on the retina for improved vision. For nearsighted people, the goal is to flatten the cornea; with farsighted people, a steeper cornea is desired. Excimer lasers also can correct astigmatism by smoothing an irregular cornea into a more normal shape.

Afterwards, the cornea flap is placed back on the cornea (like a door being closed), allowing the flap to adhere to its original position within five minutes. This enables the procedure to end in just a few short minutes, and paves the way for greatly improved vision over the next days. A day of rest is generally prescribed, although it is usually recommended that one refrains from any strenuous exercise for at least a week, since this can affect healing.

For patients undergoing Lasek Surgery, generally those with a thin cornea or with pre-existing medical conditions, an alcohol solution is put onto the surface of the eye and an ultra-thin sheet is applied. This alcohol solution loosens the thin layer of cells on the eye’s surface called the epithelium. These cells then stick to the sheet, which is then gently moved to the side of the eye, giving the surgeon access to the layer of the cornea which will be treated by the laser. Generally, Lasek Surgery takes a longer period of recovery than its counterpart Lasik.

Leading private healthcare provider, Nawaloka Hospitals, operates a state-of-the-art Lasik Centre in Colombo that has so far successfully performed over 12500 successful refractive surgeries. The centre is currently the only one-stop Lasik treatment centre in the country, enabling patients to get all the diagnostic, treatment and surgery procedures completed at one location. It is operated and lead by a team of experienced and highly skilled eye surgeons and healthcare staff, aided by a fully-equipped unit fitted with the most advanced machinery and technology capable of performing extremely delicate treatments. Nawaloka Lasik Centre offers Lasik for refractive errors, Corneal Collagen Cross Linking Treatment for Keratoconus (CXL), Corneal Collagen Cross Linking Treatment with Trans Epithelial Riboflavin Solution, Topoguided PRK, Topoguided PRK with corneal collagen cross linking treatment and Lasik extra.



Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Healthguard Distribution powers Sri Lanka’s ‘Port to Pharmacy’ medicine supply chain

Published

on

Healthguard Distribution has obtained both ISO 9001:2015 and Good Distribution Practices (GDP) certifications for all seven of its regional distribution centres across Sri Lanka.


Human resources remain the biggest challenge despite advanced logistics

Industry-wide cost pressures are also beginning to surface

In Sri Lanka’s pharmaceutical trade, the journey of a medicine does not end when it arrives at the port. It must still travel safely across the island – through regulated warehouses, temperature-controlled transport and complex distribution routes – before reaching the pharmacy shelf where patients need it.

That journey is increasingly being powered by Healthguard Distribution, the pharmaceutical logistics arm of Sunshine Holdings, whose expanding distribution network now plays a critical role in ensuring the reliable movement of medicines across the country.

At the centre of that network is the company’s Western Regional Distribution Centre (WRDC), a temperature-controlled logistics hub designed to support the safe storage and efficient distribution of pharmaceutical products across the Western Province.

Spanning nearly 18,920 square feet, the facility functions as a key node in the company’s islandwide distribution system. Originally acquired in 2008 to serve as the main warehouse for Swiss Biogenic Ltd., the site evolved alongside the company’s growing operations. Following a major upgrade programme that began in July 2024, the facility recommenced operations in July 2025 as a fully compliant regional distribution centre aligned with international quality standards.

According to Sunshine Pharmaceuticals and Healthguard Distribution Chief Executive Officer Shantha Bandara, the company’s logistics model is built around a simple but comprehensive concept.

“Our approach is ‘Port to Pharmacy’,” Bandara said during a recent media visit. “We collect pharmaceutical consignments from the Port of Colombo, clear them through Customs, store them under regulated conditions and then distribute them to pharmacies across the country. Importers and manufacturers do not have to worry about logistics – we manage the entire process.”

The distribution network today serves over 4,500 authorised pharmaceutical outlets, including pharmacies, hospitals, channeling centres, supermarkets and SPC Osusala outlets. Operations span 150 main towns and 466 sub towns, supported by 111 active delivery routes and seven regional distribution centres located across the island.

Within that system, the WRDC is the largest and among the most technologically advanced hubs.

The facility maintains strict cold-chain conditions for temperature-sensitive medicines. Its cold room capacity has been expanded from 15 cubic metres to 30 cubic metres, enabling compliant storage of products such as insulin within the required 2–8°C range. Online temperature monitoring systems operate across all storage zones while data loggers are used for insulin deliveries to ensure product integrity throughout the supply chain.

Delivery vehicles are also equipped with GPS tracking and temperature monitoring systems, allowing real-time visibility of shipments.

Automation and digital systems are increasingly shaping the operation. Software automation supports invoicing and customer credit verification, while sales teams use digital tools for order canvassing. The company’s enterprise systems provide real-time inventory and accounting visibility, supported by data dashboards used for operational decision-making.

To safeguard continuity, the facility is equipped with a high-capacity backup generator and dedicated on-site fuel storage, ensuring cold rooms, monitoring systems and warehouse operations remain functional even during power outages.

Behind the infrastructure is a workforce of 102 employees, supported by a specialised 15-member value-added services team trained in Good Distribution Practice (GDP), cold-chain management, safety and emergency response.

Yet despite the sophisticated logistics and infrastructure, Bandara told The Island that the most persistent operational challenge lies in human resources.

“We have the infrastructure, the logistics systems and the operational capability,” he noted. “However, maintaining the required number of skilled employees is an ongoing challenge because the labour market is constantly fluctuating. Our HR team is continuously recruiting and training to keep the workforce at the required level.”

Industry-wide cost pressures are also beginning to surface. Company officials noted that rising fuel prices could eventually affect transportation and electricity costs within the distribution chain, which may in turn influence pharmaceutical logistics expenses in the short term.

Still, the broader goal of the company remains unchanged – ensuring that medicines reach patients safely and on time.

From the moment a shipment arrives at the Port of Colombo to the point it reaches a pharmacy shelf, the process depends on precision logistics, regulatory compliance and operational discipline. For Sri Lanka’s healthcare supply chain, Healthguard Distribution’s growing network is becoming a key driver of that journey from port to pharmacy.

By Sanath Nanayakkare

Continue Reading

Business

From generation to generation: SINGER secures 20th consecutive People’s Brand title

Published

on

Singer team receiving the award at SLIM-KANTAR People’s Awards 2026. Pic by Kamal Bogoda and Nishendra Silva

Singer Sri Lanka, the nation’s foremost retailer of consumer durables, celebrates a truly historic milestone at the SLIM-KANTAR People’s Awards 2026, securing a prestigious triple victory while marking 20 consecutive years as the People’s Brand of the Year, an achievement made possible by the enduring trust and loyalty of Sri Lankan consumers.

This year, SINGER was honoured with yet another triple win with People’s Brand of the Year, Youth Brand of the Year and People’s Durables Brand of the Year at the awards ceremony. This remarkable recognition reflects the deep and lasting relationship the brand has built with Sri Lankans across generations, standing as a symbol of trust in homes across the island.

Janmesh Antony, Director – Marketing said: “This award belongs to our customers. Being recognised as People’s Brand for 20 years, alongside Youth and Durables Brand, reflects our commitment to staying relevant across generations.”

Mahesh Wijewardene, Group Managing Director said: “Twenty consecutive years as the People’s Brand is humbling and inspiring. This milestone strengthens our commitment to keeping customers at the heart of everything we do.”

Continue Reading

Business

Policy certainty: The real investment test for Sri Lanka in 2026

Published

on

This rendering illustrates the Ambuluwawa cable-car project’s final appearance if it were completed

When Arjuna Herath assumed duties as Chairman of the Board of Investment of Sri Lanka, he quite correctly sent a clear message: Sri Lanka intends to position itself as an investor-friendly destination. The message was reinforced during a visit by a high-level delegation from the USSri Lanka Business Council, where officials spoke of renewed confidence in the country’s economic trajectory.

The optimism is not without foundation. After years of crisis, Sri Lanka has begun to stabilize. Foreign direct investment crossed the psychological threshold of about US$1 billion in 2025, exports climbed to more than US$17 billion, and tourist arrivals reached record levels. These numbers suggest that international capital is once again willing to take a second look at the island. Yet statistics alone do not tell the whole story.

The deeper question facing policymakers in 2026 is whether that early interest can be sustained. For investors, confidence is rarely built on incentives alone; it rests on the expectation that rules will remain consistent once a project begins. In other words, predictability matters more than promises.

That tension between optimism and uncertainty is now emerging as the central theme in Sri Lanka’s investment narrative.

On the one hand, authorities are signaling reform and openness. On the other, several recent developments have reminded investors that implementation can still be uneven. One widely discussed case involved the proposed Ambuluwawa cable-car project in the hill country, where a cross-border investor withdrew after reportedly spending about US$3.5 million. The developer, Amber Adventures (Pvt) Ltd, had planned a US$12.75 million tourism venture but later said the project was halted despite earlier technical clearances from multiple agencies.

Regardless of where the merits of the dispute lie, the episode left a familiar impression in investment circles: timelines and approvals can appear uncertain once projects move from paper to construction.

A separate case in the renewable-energy sector has generated similar concerns. Policy resets and prolonged negotiations reportedly discouraged a major regional developer. Governments everywhere reserve the right to renegotiate contracts, but when processes appear open-ended, investors begin to factor in higher risk.

This is why policy certainty may be the most powerful – and least expensive – stimulus available to Sri Lanka in 2026.

The macroeconomic outlook already underscores this point. Analysts expect moderate growth in the range of about 3 – 4 percent this year, while the International Monetary Fund has projected roughly 3.1 percent, linking stronger expansion to steady reform implementation rather than new borrowing. In other words, execution matters more than announcements.

Institutional efficiency also plays a role. With more than a million cases pending in Sri Lanka’s courts, businesses often see legal delays as an additional cost of operating in the country. Reducing that backlog – particularly in commercial disputes – would signal that contracts and administrative decisions can be resolved within predictable timeframes.

Tourism offers another illustration. Visitor arrivals have surged, yet revenue growth has lagged because spending per traveller remains modest. Improving digital payments, mobility and dispute resolution may prove just as important as marketing campaigns if Sri Lanka hopes to extract greater value from the sector.

All in all, these signals reveal a simple truth. Sri Lanka does not necessarily lack investor interest; it risks losing momentum if processes remain uncertain.

For policymakers, the challenge therefore lies in bridging perception and practice. Codifying approval timelines, digitizing government services, and completing a handful of transparent public-private partnerships could quickly demonstrate that decisions in Sri Lanka are not only possible but reliable.

If that credibility gap is closed, the message delivered by the BOI chairman that Sri Lanka is open for business – will resonate far more strongly in global boardrooms. Because in frontier markets, the most valuable incentive is not a tax break or subsidy. It is certainty.

By Sanath Nanayakkare

Continue Reading

Trending